Item 8.01 Other Events.
On November 18, 2020, Akers Biosciences, Inc. (the "Company") issued a press
release announcing that MyMD Pharmaceuticals, Inc. and the Company plan to hold
a video conference for investors on Wednesday, November 18, 2020 at 4:15 p.m. ET
to provide additional context on the integrated company, the clinical pipeline
and drug development plan, and the commercial potential of the targeted
indications. A copy of the press release is attached as Exhibit 99.1 to this
Current Report on Form 8-K and is hereby incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
99.1 Press release, dated November 18, 2020.
© Edgar Online, source Glimpses